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Diffusion and social networks: revisiting medical innovation with agents
Abstract
the classic study on diffusion of Tetracycline by Coleman, Katz and Menzel (1966). Medical Innovation
articulates how different patterns of interpersonal communications can influence the diffusion process at
different stages of adoption. In their pioneering study, individual network (discussion, friendship or
advice) was perceived as a set of disjointed pairs, and the extent of influences were therefore, evaluated
for pairs of individuals. Given the existence of overlapping networks and consequent influences on
doctors’ adoption decisions, the complexity of actual events was not captured by pair analysis.
Subsequent reanalyses (Burt 1987, Strang and Tuma 1993, Valente 1995, Van den Bulte and Lilien 2001)
failed to capture the complexity involved in the diffusion process and had a static exposure of the
network structure. In this paper, for the first time, we address these limitations by combining Agent-Based
Modeling (ABM) and network analysis. Based on the findings of Coleman et. al. (1966) study, we develop
a diffusion model, Gammanym. Using SMALLTALK programming language, Gammanym is developed with
CORMAS platform under Visual Works environment. The medical community is portrayed in an 8 X 8
spatial grid. The unit cell captures three different locations for professional interactions: practices,
hospitals, and conference centers, randomly located over the spatial grid. Two social agents- Doctor and
Laboratory are depicted in the model. Doctors are the principal agents in the diffusion process and are
initially located at their respective practices. A doctor’s adoption decision is influenced by a random
friendship network, and a professional network created through discussions with office colleagues, or
hospital visits or conference attendance. A communicating agent, Laboratory, on the other hand,
influences doctors’ adoption decisions by sending information through multiple channels: medical
representatives or detailman visiting practices, journals sent to doctors’ practices and commercial flyers
available during conferences. Doctors’ decisions to adopt a new drug involve interdependent local
interactions among different entities in Gammanym. The cumulative adoption curves (Figure 1) are
derived for three sets of initial conditions, based on which network topology and evolution of uptake are
analyzed. The three scenarios are specified to evaluate the degree of influences by different factors in the
diffusion process: baseline scenario with one seed (initial adopter), one detailman and one journal; heavy
media scenario with one seed but increasing degrees of external influence, with five detailman and four
journals; and integration scenario with one seed, without any external influence from the laboratory.
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adoption decisions by sending information through
multiple channels: medical representatives or
detailman visiting practices, journals sent to
doctors’ practices and commercial flyers available
during conferences. Doctors’ decisions to adopt a
new drug involve interdependent local interactions
among different entities in Gammanym.

EXTENDED ABSTRACT
In this paper, we reanalyze Medical Innovation,
the classic study on diffusion of Tetracycline by
Coleman, Katz and Menzel (1966). Medical
Innovation articulates how different patterns of
interpersonal communications can influence the
diffusion process at different stages of adoption.
In their pioneering study, individual network
(discussion, friendship or advice) was perceived
as a set of disjointed pairs, and the extent of
influences were therefore, evaluated for pairs of
individuals. Given the existence of overlapping
networks and consequent influences on doctors’
adoption decisions, the complexity of actual
events was not captured by pair analysis.
Subsequent reanalyses (Burt 1987, Strang and
Tuma 1993, Valente 1995, Van den Bulte and
Lilien 2001) failed to capture the complexity
involved in the diffusion process and had a static
exposure of the network structure. In this paper,
for the first time, we address these limitations by
combining Agent-Based Modeling (ABM) and
network analysis.

The cumulative adoption curves (Figure 1) are
derived for three sets of initial conditions, based on
which network topology and evolution of uptake
are analyzed. The three scenarios are specified to
evaluate the degree of influences by different
factors in the diffusion process: baseline scenario
with one seed (initial adopter), one detailman and
one journal; heavy media scenario with one seed
but increasing degrees of external influence, with
five detailman and four journals; and integration
scenario with one seed, without any external
influence from the laboratory.
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Based on the findings of Coleman et. al. (1966)
study, we develop a diffusion model, Gammanym.
Using SMALLTALK programming language,
Gammanym is developed with CORMAS
platform under Visual Works environment. The
medical community is portrayed in an 8 X 8
spatial grid. The unit cell captures three different
locations for professional interactions: practices,
hospitals, and conference centers, randomly
located over the spatial grid. Two social agentsDoctor and Laboratory are depicted in the model.
Doctors are the principal agents in the diffusion
process and are initially located at their respective
practices. A doctor’s adoption decision is
influenced by a random friendship network, and a
professional network created through discussions
with office colleagues, or hospital visits or
conference attendance. A communicating agent,
Laboratory, on the other hand, influences doctors’
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Figure 1: Cumulative Diffusion Curves for three
scenarios: Baseline (Series 1), Heavy Media (Series
2) and Integration (Series 3)
Averaged over an ensemble of 100 runs, clustering
coefficient and average shortest path length indicate
that social networks depicted in Gammanym are
random graphs. Evolution of uptake suggests that
although the degree of external influence in terms
of marketing strategies adopted by the
pharmaceutical company does not have impact on
the network structure, the speed of diffusion is
largely determined by it.
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1.

influenced by the people they are connected with,
either socially or professionally.

INTRODUCTION

In this paper we reanalyze Medical Innovation by
Coleman et. al. (1966), the classic study on
diffusion of Tetracycline, which at that time was a
newly introduced antibiotic. Their pioneering
study elaborated on how different patterns of
interpersonal communications can influence the
diffusion of a medical innovation in four medical
communities in Illinois. The motivation for our
reanalysis is to capture the complex interactions
involved in the diffusion process by combining
Agent-based Modeling (ABM) and network
analysis. Based on the findings in Medical
Innovation, we develop a diffusion model called
Gammanym. The topology of networks generated
in Gammanym, and its evolution, are analyzed to
evaluate how, and to what extent, network
structure influences the diffusion process.

2.
2.1.

DIFFUSION AND NETWORKS
Diffusion of Tetracycline

Tetracycline was launched in November 1953.
Four US Midwestern cities: Peoria, Bloomington,
Quincy and Galesburg, were selected for the
original study. The sample constituted 148 general
practitioners, internists, and pediatricians in active
practice, of which 126 (85% of the sample) were
interviewed. In an attempt to evaluate the
importance of social networks, each of them was
asked about their close associates (e.g., friends,
colleagues and advisors) in the medical
community. A prescription audit in the local
pharmacies was carried out for 125 doctors (121
general practitioners, internists, and pediatricians
and 4, listed as surgeons or proctologists) over a
16-month period following the release of
Tetracycline for general sale. Prescriptions were
edited for three successive days at approximately
monthly intervals (Coleman et. al. 1966: 194).
Their study identifies two broad categories of
variables influencing the diffusion process. First
category describes personal traits or individual
variables, affecting individual receptivity: 1. type
of practice, 2. medical background, 3. contacts
with out-of-town institutions, 4. media behavior,
and 5. orientations and attitudes. Second category
defines social variables influencing the adoption
process as a result of professional ties created
through hospital affiliation and shared office, or
social ties to other members of the community.
Their analyses revealed that doctors’ decisions to
adopt Tetracycline, the new drug, were strongly
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We have reviewed four reanalyses of Medical
Innovation. The authors differed in terms of their
methods as well as their perspectives on the
process of diffusion. Burt (1987) argues that where
contagion occurred, its effect was through
structural equivalence not cohesion. Strang and
Tuma (1993) apply an event-history framework
incorporating spatial and temporal heterogeneity.
Their results contradicts Burt, as they opine,
“Cohesive ties based on advice giving and
discussion also contribute to diffusion, as do
structures of similarity in physicians’ orientation
towards their work (Strang and Tuma 1993: 638).”
Valente (1995) tests his threshold/critical mass
(T/CM) model on medical innovation data and
indicates that the opinion leaders, who have greater
exposure to external influence, play a dominant
role in the diffusion process. A study by Van den
Bulte and Lilien (1999, 2001) provides strong
support for external influence in the diffusion
process by incorporating a data set
on
advertisement volume. The authors conclude that
the data do not show that diffusion was driven by
contagion operating over social networks, and that
earlier analyses confounded social contagion with
the effect of marketing effort (Van den Bulte and
Lilien 2001).
2.2.

Rationale for Gammanym

The major limitation of all the previous studies is
their static exposition of network structure, which
falls short of representing the evolving process.
These dynamics can be described by the Dynamics
of the network, or Dynamics on the network (Watts
2003). Until now, however, neither medical
innovation study nor the subsequent reanalyses of
the original dataset incorporated any of those
dynamic
features.
Our
study,
therefore
complements the extant work.
Our study also makes contribution in that the
complexity generated in the diffusion process has
not been examined by any previous studies. In
Medical Innovation, the extent of influence was
evaluated for pairs of individuals. Individual
network (discussion, friendship or advice) was,
therefore, perceived as a set of disjointed pairs.
Given the existence of overlapping networks and
consequent influences on doctors’ adoption
decisions, the complexity of actual events was not
captured by pair analysis. ABM enables us to
address this limitation in previous studies by
considering the whole network as a unit of
analysis.

3.

MODELLING FRAMEWORK

3.2.1 Located and Communicating Agents:
Doctors

Using SMALLTALK programming language, we
develop Gammanym with the CORMAS platform
(Common-pool Resources and Multi-Agent
Systems, http://cormas.cirad.fr) under Visual
Works environment.
3.1. Spatial Representation and Passive
objects
We portray the medical community in a 8 X 8
spatial grid. The unit cell captures three different
locations for professional interactions: Hospitals,
Practices and Conference Center, which are
created as Passive objects. Gammanym has sixtyone practices, two hospitals and one conference
center, randomly located over the spatial grid. In
the original study, on average 47% of doctors were
alone in office, 20% were in clinics, 17% were
working with two colleagues and 15% were
sharing office with one colleague. We captured the
categories of office partnership into three practice
types: Private (alone in office), Center (shared
office with two partners) and Clinic (working with
four colleagues). The doctors are thus located
among 46 private, 11 centers and 4 clinics.
Gammanym specifies two hospitals, as all the
cities, on average, have two hospitals. Conference
center, the third passive entity, provides the
context in which a much larger group of
professionals can interact with each other. Random
allocation of these practices over the grid reflects
that spatial representation is not sensitive to
distances. In other words, the doctors’ decision to
go to hospitals or the conference center, do not
depend on the location of their practices; as the
grid does not incorporate any Geographic
Information System (GIS) specifications. This
inclusion was not possible, as we do not have the
original data set. GIS specifications, on the other
hand, would add little to our analysis in the sense
that the significance of physical distance in
diffusing a new idea can, and is, well captured by
our definition of discussion networks. Without GIS
specifications real distance between cells have no
impact on the doctors decision to move from office
to hospitals or conference centers.
3.2.

Social agents

Gammanym depicts two kinds of social agentsDoctor and Laboratory. Initially located in their
respective practices, 99 doctors are created. A
laboratory (LAB from hereon), on the other hand,
influences doctors’ adoption decisions by sending
information through multiple channels: medical
representatives, journals and commercial flyers.
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In Gammanym, Doctors are specified with the
attributes generating network effects only.
Individual traits have impacts on the adoption
decision. Nevertheless, we opt for this
simplification on the basis of the correlation
coefficient estimated in medical innovation. Four
network variables, shared office, advice seeking,
discussion and friendship, showed a strong
association to the date of first use of Tetracycline
than any other individual variables, with the single
exception of total volume of prescriptions for the
class of drugs. Holding the volume of prescriptions
constant, the association between integration and
adoption increased (Coleman et. al. 1966: 92).
Thus, we explore if all the doctors are homogenous
in terms of their individual attributes, to what
extent does integration matter for adoption
decision?
Professional interactions are spatially defined,
based on which Gammanym builds discussion
networks. We do this to signify the importance of
tacit knowledge or non-codified knowledge, which
requires face-to-face contacts for its transmission.
The doctors, therefore, consider the others as
discussion partners if they are situated in the same
cell. After each visit to hospital or conference
centers, doctors return back to their practices. The
friendship network, on the other hand, is random
in nature as the doctors are initialized with random
number of friends and counter for friends; both
ranging from 0-3. We treated the indices of
similarity derived in the original study with
reservation, because of their limited statistical
relevance for only 111 friendship pairs (Coleman
et. al. 1966: 143).
3.2.2. Communicating Agents: Laboratory
LAB adopts a mixed marketing strategy with three
different channels to send information about the
new drug: i. Detailman (pharmaceutical
representative) visiting practices; ii. Flyers,
available at the conferences; iii. Journals, sent to
doctors’ practices.
In Gammanym the detailman visits all the doctors
at their practices. Assuming similar influences by
direct mail advertising and journal insertions, we
specify journals as the second instrument for the
LAB. We introduce flyers at the conference centers
as an additional marketing tool. To avoid the
notion of blanket exposure to all doctors, we
specify the criterion that LAB sends flyers based
on the number of previous conference participants.

3.4 Adoption Process/Decision-making process
Doctors’ decisions to adopt a new drug involve
interdependent local interactions among different
entities in Gammanym. Diffusion scholars have
long recognized that individual’s decision about
adoption is a process that occurs over time,
consisting of several stages (Coleman et. al. 1966;
Rogers 1995). We specify five stages of adoption:
1. Awareness or knowledge, 2. Interest, 3.
Evaluation/mental trial, 4. Trial, and 5.
Adoption/acceptance. In our model readiness is
specified as the attribute signifying the above
stages of adoption. All doctors are initialized with
readiness 4. Readiness is decremented when they
receive an alert from different sources.
Discussions with other doctors, either friends or
colleagues at practices, conferences, or hospitals
generate an alert when the mean adoption rate is
0.50 or above. In case of the LAB, on the other
hand, an alert is created each time a doctor
received information from the detailman, flyers or
journals. Doctors’ readiness is gradually reduced
with alerts from all the aforementioned sources.
When
the
readiness
reaches
zero
(Adoption/acceptance stage), doctors adopt the
new drug.
3.5 Modeling Sequence
Gammanym is divided into four phases: i)
managing professional interactions; ii) external
influence; iii) decision making process; and iv)
networks formation. At each time step,
Gammanym resets the attributes of the practices.
Thus, the doctors are at their respective practices at
the beginning of each simulation.
Phase I entails the methods for doctors’
professional interactions. Primarily, the doctors
interact with the office colleagues at their
practices. Hospitals are another location for
professional interactions, where they have their
monthly visits. The third location for information
exchange is the conference center, as the doctors
move from their practices to there after receiving
invitations. Phase II depicts the mixed marketing
strategy adopted by the LAB. At each time step,
the LAB targets practices from the unvisited ones
and send the detailman if the doctors are available.
After receiving an invitation for a conference from
the conference center, the LAB sends flyers to the
conference center based on number of previous
conference attendees. LAB issues journals only
when the number of newly adopted doctors in the
previous time step, i.e., the last increment, is less
than half of the average number of adopted
doctors. Phase III is the decision-making process
based on readiness. Phase IV constitutes the
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methods for network formation. At each time step,
the network matrices for professional networks and
friendship networks contain the number of
interpersonal interactions for each doctor. The
adoption matrix, on the other hand, specifies the
adoption status at each time step for all the doctors.

4.

SIMULATION RESULTS

In this section our discussion traces through the
shape of the cumulative diffusion curves under
three scenarios. The three scenarios are specified
to evaluate the degree of influences by different
factors in the diffusion process: i. Baseline
Scenario; with one ‘seed’ or initial adopter, one
detailman and one journal; ii. Heavy Media
Scenario; with one initial adopter, five detailman
and four journals; iii. Integration Scenario; one
initial adopter, without any external influence from
the LAB. All three scenarios have been run over a
68 weeks or 17 months which was the time length
for original study. As several random functions are
included in the algorithm, each scenario is repeated
100 times in order to estimate the output’s
variability. For each of the cases, the seed or the
innovator is chosen among the doctors who are
practicing at centers, i.e. doctors who have two
colleagues.
The cumulative diffusion curve (CDC),
representing the total number of adopted doctors at
each time step is shown in Figure 1. All three
curves are derived after averaging over 100
simulations. Baseline scenario (Figure 1: Series 1)
with one innovator and one detailman generated a
logistic or S-shaped curve, similar to those found
in cases of mixed influence diffusion models
(Ryan and Gross 1943; Mahajan and Peterson
1985; Rogers 1995; Valente 1993). In this
scenario, our model reveals an adoption curve with
an initial phase of slow diffusion until the first
inflection point at the 24-time step where 23% of
doctors have adopted the new drug. Thereafter, the
rate of adoption speeds up as more doctors are
exposed to someone who has already adopted and
gradually begins to level off as fewer doctors
remain in the population who are yet to adopt.
The steepest diffusion curve (Figure 1: Series 2)
represents a heavy media scenario, where 50% of
the population adopts the new drug at the end of
12 weeks. The rate of diffusion increases up to 16
time steps and decreases afterwards as only 18% of
doctors at that time have failed to adopt and
remain unaffected. At the 25 time step, the CDC
levels off as all the doctors have adopted the new
drug. The integration scenario represents an
extremely slow diffusion process (Figure 1: Series

3). As the only means to have an alert is to be in
contact with the initial adopter, only 18% of the
population adopt the new innovation at the end of
68 times.

A network is said to have small world properties
if, compared to an Erdös-Rényi random graph, the
following conditions hold: the average shortest
path length, PL ≈ PLrand ; and clustering

5.

coefficient, CC >> CCrand .

NETWORK ANALYSIS

5.1. Network Topology
We first calculate the degree distribution to
identify the class of networks the ABM interaction
networks from four possible alternatives: (1)
regular lattices; (2) random graphs (Erdös and
Rényi 1959) (3) small world networks (Watts and
Strogatz 1998); and (4) scale-free networks
(Barabási 2002). Our simulations produce a degree
distribution (Figure 2) that conforms to a binomial
distribution, which suggests that the networks are
most likely either a random graph, or a small
world network (Watts 1999).

The

comparison

between the interaction networks generated by the
simulation model, and an ensemble of random
graphs reveals that PLmodel ≈ PLrand and

CCmodel ≈ CCrand .

This suggests that the

networks depicted in Gammanym are random
graphs.
5.2 Evolution of Networks
The evolution of social networks in Gammanym
has been analyzed to gain an understanding of the
diffusion process. As agents interact with each
other, new connections (relationships) form
between agents, while others are reinforced. In
order to study the nature and structure of clusters,
we define a cluster as a set of agents that are
connected. That is, there exists a path from any
agent to any other agent within that cluster. At
each time step within the simulation we count the
number of groups of agents and calculate the
maximum, minimum, average cluster size,
standard deviation in cluster size and the average
shortest path length between agents within the
system. All statistics were averaged over an
ensemble of 100 runs. Figure 3 shows how the
clusters of agents evolve over time.

Figure 2: Degree distribution created of the
interaction networks in Gammanym

Figure 3: Network statistics. (A) Number of clusters; (B) Maximum cluster size; (C) Minimum cluster size;
(D) Average cluster size; (E) Standard deviation in cluster size; (F) Average shortest path-length.
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From Figure 3, we see that initially the simulation
contains approximately 60 clusters of agents
(Figure 3A). As new interactions occur, the
number of clusters quickly decays. Similarly, the
maximum cluster size grows rapidly (Figure 3B).
The minimum and average cluster sizes quickly
explode as the agents become consumed by the
giant cluster (Figures 3(C–D)). The system begins
to behave as one giant cluster after about 7–10
time steps. The standard deviation in cluster size is
maximized just before the emergence of a fully
connected system (Figure 3E). We note that the
average shortest path length between nodes
initially increases rapidly, as more and more nodes
become connected to the giant cluster. When the
system becomes connected, such that there exists a
path between all agents, the average shortest pathlength between any two nodes is on average is
relatively long. This is because of the sparsity of
interaction matrices and the network containing
many long paths.
However, as the system
increases in connectivity the path-lengths become
smaller until there is approximately two degrees of
separation between any two agents within the
system (Figure 3F). In short, the system initially
consists of a number of disconnected components,

but quickly evolves to form a single connected
component
5.3 Evolution of Uptake
To analyze the differences in the speed of diffusion
depicted in Section 4, we can look at how
Tetracycline uptake evolves under three scenarios.
We, therefore, define an uptake cluster as a set of
agents who are connected to each other and each
agent has adopted Tetracycline. In this context the
uptake cluster can be thought of as a cluster
commonly encountered in percolation studies
(Stauffer 1979). Figure 4 shows how the uptake of
Tetracycline evolves through time. In the base
scenario, starting from one seed (innovator) the
average number of uptake clusters increases up to
1.6 at time step 15 (Figure 4A). Then, it decreases
to one giant cluster (time step 30) as the size of the
existing clusters increases gradually before
merging. In Figure 4 (A) we also observe that the
number of uptake clusters explodes rapidly under
the heavy media scenario (Figure 4A). Under
integration scenario, one average, only one uptake
cluster is formed during 68 time steps (Figure 4D)
and its maximum size (Figure 4B) barley reaches
20
at
the
end
of
simulation.

Figure 4: Uptake clusters for three scenarios (A) Number of clusters within the system; (B) Maximum
cluster size; (C) Minimum cluster size; (D) Average cluster size; and (E) Standard deviation of cluster size.
6.

CONCLUSIONS

We develop an agent-based model, called
Gammanym, to analyze the diffusion process. This
is inspired by the classic Medical Innovation study
on the adoption of Tetracycline in the Midwestern
US in 1950s by Coleman et. al. (1966). Due to the
limited availability of proper technique or methods
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during 1950s, the original study focused on
interpersonal influence for pairs of individuals.
This approach, however, fails to capture the
complexity and dynamics of actual adoptions. In
our study, we overcome this limitation using
agent-based modeling to consider the whole
network as a unit of analysis. Our model brings
original features within the existing literature of

diffusion research and also complements the extant
work on medical innovation.
In our study we also examine the diffusion process
by applying the core concepts of network theory.
On the basis of network properties we determine
that the interaction networks depicted in the model
are random graphs. Complexity of the diffusion
process is explained by analyzing evolution of
networks or dynamics on the networks. We find
that initially the system consisted of a number of
disconnected components and quickly evolves,
after 7-10 time steps, to form a single connected
component. The analysis of network topology also
indicates that underlying networks evolve in
predictable ways, and the uptake is a function of
initial starting condition.
Analyses of the evolution of uptake and adoption
of Tetracycline enable us to disentangle the extent
of different factors affecting adoption. Despite
stressing the complementarity between network
theory and diffusion research, a large body of
diffusion literature has so far failed to examine the
dynamic structures of the interpersonal networks
and their evolutions over the diffusion process.
Our model shows that although the media does not
influence the network structure, it does have a
major impact in accelerating the diffusion process.
Under a heavy media exposure undertaken by the
pharmaceutical company to increase sale of
Tetracycline, the average size of clusters with
agents who have adopted the new drug rise faster
than otherwise. Moreover, all the agents adopt the
new drug within 25 time steps, much earlier than
that with a baseline scenario with much less media
exposure.
We also compare the cumulative diffusion curves
of Gammanym with those of medical innovation.
The cumulative diffusion curve under the heavy
media scenario with initial speedy diffusion
resembles more the one in the original study,
compared to that of the typical S-shaped diffusion
curve generated under baseline scenario or mixed
influence diffusion. In conclusion, our results
provide support to the importance of social
networks in the diffusion process, but also show
that external influences play a dominant role in
speeding up the rate of adoption.
7.
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